These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 11192456

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Copper, zinc, and selenium in human blood and urine after injection of sodium 2,3-dimercaptopropane-1-sulfonate: a study on subjects with dental amalgam.
    Høl PJ, Vamnes JS, Gjerdet NR, Eide R, Isrenn R.
    Biol Trace Elem Res; 2003 Jan; 91(1):19-31. PubMed ID: 12713026
    [Abstract] [Full Text] [Related]

  • 3. Mobilization of mercury and arsenic in humans by sodium 2,3-dimercapto-1-propane sulfonate (DMPS).
    Aposhian HV.
    Environ Health Perspect; 1998 Aug; 106 Suppl 4(Suppl 4):1017-25. PubMed ID: 9703487
    [Abstract] [Full Text] [Related]

  • 4. Urinary mercury in twelve cases of cutaneous mercurous chloride (calomel) exposure: effect of sodium 2,3-dimercaptopropane-1-sulfonate (DMPS) therapy.
    Garza-Ocañas L, Torres-Alanís O, Piñeyro-López A.
    J Toxicol Clin Toxicol; 1997 Aug; 35(6):653-5. PubMed ID: 9365436
    [Abstract] [Full Text] [Related]

  • 5. Urinary mercury after administration of 2,3-dimercaptopropane-1-sulfonic acid: correlation with dental amalgam score.
    Aposhian HV, Bruce DC, Alter W, Dart RC, Hurlbut KM, Aposhian MM.
    FASEB J; 1992 Apr; 6(7):2472-6. PubMed ID: 1563599
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. DMPS (2,3-dimercaptopropane-1-sulfonate, dimaval) decreases the body burden of mercury in humans exposed to mercurous chloride.
    Gonzalez-Ramirez D, Zuniga-Charles M, Narro-Juarez A, Molina-Recio Y, Hurlbut KM, Dart RC, Aposhian HV.
    J Pharmacol Exp Ther; 1998 Oct; 287(1):8-12. PubMed ID: 9765315
    [Abstract] [Full Text] [Related]

  • 10. Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans: II. Urinary mercury, porphyrins and neurobehavioral changes of dental workers in Monterrey, Mexico.
    Gonzalez-Ramirez D, Maiorino RM, Zuniga-Charles M, Xu Z, Hurlbut KM, Junco-Munoz P, Aposhian MM, Dart RC, Diaz Gama JH, Echeverria D.
    J Pharmacol Exp Ther; 1995 Jan; 272(1):264-74. PubMed ID: 7815341
    [Abstract] [Full Text] [Related]

  • 11. Symptoms and differential diagnosis of patients fearing mercury toxicity from amalgam fillings.
    Stenman S, Grans L.
    Scand J Work Environ Health; 1997 Jan; 23 Suppl 3():59-63. PubMed ID: 9456068
    [Abstract] [Full Text] [Related]

  • 12. Dental amalgam affects urinary selenium excretion.
    Høl PJ, Vamnes JS, Gjerdet NR, Eide R, Isrenn R.
    Biol Trace Elem Res; 2002 Feb; 85(2):137-47. PubMed ID: 11899021
    [Abstract] [Full Text] [Related]

  • 13. Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans. III. Urinary mercury after exposure to mercurous chloride.
    Maiorino RM, Gonzalez-Ramirez D, Zuniga-Charles M, Xu Z, Hurlbut KM, Aposhian MM, Dart RC, Woods JS, Ostrosky-Wegman P, Gonsebatt ME, Aposhian HV.
    J Pharmacol Exp Ther; 1996 May; 277(2):938-44. PubMed ID: 8627576
    [Abstract] [Full Text] [Related]

  • 14. DMPS-arsenic challenge test. I: Increased urinary excretion of monomethylarsonic acid in humans given dimercaptopropane sulfonate.
    Aposhian HV, Arroyo A, Cebrian ME, del Razo LM, Hurlbut KM, Dart RC, Gonzalez-Ramirez D, Kreppel H, Speisky H, Smith A, Gonsebatt ME, Ostrosky-Wegman P, Aposhian MM.
    J Pharmacol Exp Ther; 1997 Jul; 282(1):192-200. PubMed ID: 9223554
    [Abstract] [Full Text] [Related]

  • 15. Mobilized mercury in subjects with varying exposure to elemental mercury vapour.
    Molin M, Schütz A, Skerfving S, Sällsten G.
    Int Arch Occup Environ Health; 1991 Jul; 63(3):187-92. PubMed ID: 1917069
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effect of 2,3-dimercaptopropane sodium sulfonate on mercury retention in rats in relation to age.
    Kostial K, Kargacin B, Blanusa M, Landeka M.
    Arch Toxicol; 1984 Oct; 55(4):250-2. PubMed ID: 6517703
    [Abstract] [Full Text] [Related]

  • 18. Influence of 2,3-dimercaptopropane-1-sulfonate (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the renal disposition of mercury in normal and uninephrectomized rats exposed to inorganic mercury.
    Zalups RK.
    J Pharmacol Exp Ther; 1993 Nov; 267(2):791-800. PubMed ID: 8246154
    [Abstract] [Full Text] [Related]

  • 19. [Diagnosis and treatment of an alleged mercury and lead exposure with DMPS].
    Hakimi R.
    Versicherungsmedizin; 2014 Dec 01; 66(4):210-2. PubMed ID: 25558512
    [No Abstract] [Full Text] [Related]

  • 20. Plasma and urine dimercaptopropanesulfonate concentrations after dermal application of transdermal DMPS (TD-DMPS).
    Cohen JP, Ruha AM, Curry SC, Biswas K, Westenberger B, Ye W, Caldwell KL, Lovecchio F, Burkhart K, Samia N.
    J Med Toxicol; 2013 Mar 01; 9(1):9-15. PubMed ID: 23143832
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.